Attending Biotech and Pharma
BOS Copenhagen 2008 Programme
BOS Copenhagen brings together a distinguished group of independent UK consultants to inpart their knowledge on CMC aspects of drug discovery and development. We are pleased to wellcome to Copenhagen the following speakers.....
- Dr Paul Madeley, Managing Director of Synth-Isis Ltd
- Dr Rolland Collicott, ChalPharm Consultancy
- Prof Karrar Khan, Independent Consultant
- Mr Neil Graham, Managing Director, Enpharma Ltd
All speakers are experts in the fields of PR&D, analytical method development, formulation and regulatory affairs respectively. Please see the speaker profiles section of the website for further speaker information.
| Provisional Programme: Biotech Outsource Strategies 2008 |
|
|---|---|
| 08.30 - 09.00 | Registration and coffee |
| 0900-1600 | Chairman for the day
Dr Mario Rottländer, H Lundbeck A/S |
| 09.00 - 09.45 | Outsourcing small molecules (40 + 5 min)
Dr Paul Madeley, Synth-Isis Ltd |
| 09.45 - 09.55 | Custom pharmaceutical services
Ravi Venkataramanan, Dr Reddy's Laboratories UK Ltd |
| 09.55 - 10.05 | Innovative chemistry to accelerate research
Ed Dutton, Peakdale Molecular Ltd |
| 10.05 - 10.15 | How do Asian CROs close the performance gap?
by Dr Andrew Lamb, Sai Advantium Pharma |
| 10.15 - 10.25 | An Onyx approach to CR&D
Bryan Fleming, Onyx Scientific Ltd |
| 10.25 - 10.35 | Chemistry services to support all phases of drug development and commercial drug substance supply
Dr Marcel Hogerheide, Carbogen Amcis |
| 10.35 - 10.40 | Q&A for all speakers |
| 10.40 - 11.15 | Coffee and partnering |
| 11.15 - 12.00 | Analytical method development within a biotech setting and managing contractor relationships to achieve success (40 + 5 min)
Dr Roland Collicott, ChalPharm Consultancy |
| 12.00 - 12.10 | Blood-brain barrier solutions
Dr Mohammad Alavijeh, Pharmidex |
| 12.10 - 12.15 | Q&A for all speakers |
| 12.15 - 13.45 | Lunch and partnering |
| 13.45 - 14.35 | Preclinical and first in man strategies for emerging biotech (45 + 5 min)
Prof Karrar Khan, Independent Consultant |
| 14.35 - 14.45 | Strategies for developing poorly soluble APIs
Chris Landeg, Pharmaterials Ltd |
| 14.45 - 15.15 | Coffee and partnering |
| 15.15 - 16.00 | Regulatory affairs - adding value throughout development
Mr Neil Graham, Enpharma Ltd |
| 16.00 onwards | Drinks reception |
Key Sponsors
Gold CRO Sponsors
Silver CRO Sponsor
